Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity

PURPOSE: To describe the efficacy of intravitreal bevacizumab for the treatment of type 1 retinopathy of prematurity (ROP) in zone I. METHODS: Preterm infants with type 1 ROP in zone I (zone I ROP, any stage with plus disease or zone I ROP, stage 3 without plus disease) were enrolled in this prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Karkhaneh, Reza, Torabi, Hamidreza, Khodabande, Alireza, Roohipoor, Ramak, Riazi-Esfahani, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782452/
https://www.ncbi.nlm.nih.gov/pubmed/29403586
http://dx.doi.org/10.4103/jovr.jovr_198_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782452/
https://www.ncbi.nlm.nih.gov/pubmed/29403586
http://dx.doi.org/10.4103/jovr.jovr_198_16

Ejemplares similares